E Robberecht
Overview
Explore the profile of E Robberecht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casier A, Goubert L, Huse D, Theunis M, Franckx H, Robberecht E, et al.
Psychol Health
. 2014 Aug;
23(5):629-38.
PMID: 25160724
This study explored the role of acceptance in accounting for the heterogeneity in psychological functioning in adolescents suffering from cystic fibrosis. Thirty-four adolescents completed a battery of questionnaires assessing acceptance,...
2.
Robberecht E, Vandewalle S, Wehlou C, Kaufman J, De Schepper J
Eur J Clin Nutr
. 2011 Jan;
65(5):574-9.
PMID: 21245888
Background/objectives: The increase of bone disease in adult cystic fibrosis (CF) patients is partly attributed to inadequate serum concentrations of 25-OH cholecalciferol (25 (OH) D) blamed on fat malabsorption. Based...
3.
Van Biervliet S, Vande Velde S, Van Biervliet J, Robberecht E
Ann Nutr Metab
. 2008 May;
52(2):152-6.
PMID: 18446019
Aim: To study the effect of Zn supplements in cystic fibrosis (CF) on disease evolution. Methods: A retrospective study of all CF patients treated with Zn supplements (January 2002 to...
4.
Van Biervliet S, Devos M, Delhaye T, Van Biervliet J, Robberecht E, Christophe A
Prostaglandins Leukot Essent Fatty Acids
. 2008 Feb;
78(2):109-15.
PMID: 18276127
Aim: The aim of this study was to evaluate whether the previously observed changes in the fatty acid profile, as a result of DHA supplementation, could be maintained during longer...
5.
Vande Velde S, Van Biervliet S, Robberecht E
Acta Gastroenterol Belg
. 2007 Dec;
70(3):300-1.
PMID: 18074742
The diagnosis of cystic fibrosis (CF) can be confusing when only a part of the typical symptoms is present. In children, CF is usually suspected when dealing with chronic pulmonary...
6.
Van Biervliet S, Van Biervliet J, Vande Velde S, Robberecht E
Biol Trace Elem Res
. 2007 Oct;
119(1):19-26.
PMID: 17914215
Aim: Assess the risk of zinc (Zn) deficiency in the older cystic fibrosis (CF) population. Method: Cross-sectional investigation of all CF patients above the age of 4 followed at the...
7.
Van Biervliet S, Vande Velde S, Robberecht E, Van Winckel M
Acta Gastroenterol Belg
. 2007 Aug;
70(2):243-4.
PMID: 17715644
We describe a baby admitted with convulsions, fever, low protein level and coagulation abnormalities where congenital intestinal lymphangiectasia was confirmed by endoscopy and histology. Treatment with a low fat diet,...
8.
Van Biervliet S, Raes A, Vande Walle J, Van Winckel M, Robberecht E, Praet M
Acta Gastroenterol Belg
. 2006 Dec;
69(3):321-2.
PMID: 17168131
Mesalazine is the first line treatment in paediatric inflammatory bowel disease (IBD). There are several reports in the literature about nephrotoxicity (1/150 treated patients), from renal insufficiency to reversible nephritis....
9.
Van Biervliet S, Van Biervliet J, Robberecht E
Biol Trace Elem Res
. 2006 Oct;
112(3):205-11.
PMID: 17057259
There is no consensus whether zinc (Zn) supplementation is necessary in cystic fibrosis (CF). For assessment of the Zn status, serum Zn concentration is the only easy available method. It...
10.
Robberecht E, Maesen S, Jonckheere A, Van Biervliet S, Carton D
J Inherit Metab Dis
. 2006 Apr;
29(1):184-5.
PMID: 16601888
Liver transplantation was performed in a girl with early-onset ASLD, leading to unrestricted protein intake and no further neurological deterioration.